Search results
Results from the WOW.Com Content Network
Quantum Pharma Plc (LSE: QP) [3] is a manufacturer and supplier of unlicensed medicines and Special Obtain products based in Burnopfield, County Durham. [1] As of 2014, Andrew Scaife was the company's chief executive officer (CEO), [ 3 ] who had joined the company's management team in 2009.
While Aesica, Piramal, MSD (Northumberland), Sanofi (Tyne & Wear), GlaxoSmithKline, Quantum Pharmaceuticals [61] and Bristol Laboratories [62] in (County Durham) are all secondary pharmaceutical manufacturers with large facilities in the region. These companies formulate and package finished pharmaceuticals ready for consumer use.
Alcon – Alcon Laboratories (UK) Ltd; ALK-Abelló – ALK-Abelló (UK) Ltd; Allergan – Allergan Ltd; Alpharma – King Pharmaceuticals; Almus Pharmaceuticals - Walgreens Boots Alliance; Altana – Altana Pharma Ltd; Amgen – Amgen Ltd; APS – TEVA UK Ltd; Assertio – Assertio Therapeutics, Inc; AstraZeneca – AstraZeneca UK Limited ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Boehringer Ingelheim is the first pharmaceutical company worldwide to join forces with Google in quantum computing in a newly established Quantum Lab of Boehringer Ingelheim. [54] Boehringer Ingelheim is also a founding member of the Quantum Technology and Application Consortium (QUTAC).
The "second quantum revolution", or "quantum 2.0" is a term that is often used to describe quantum technologies based on superposition and entanglement. Originally described in a 1997 book by Gerard J. Milburn, [2] which was then followed by a 2003 article by Jonathan P. Dowling and Gerard J. Milburn, [3] [4] as well as a 2003 article by David Deutsch. [5]
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
[1] [2] In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion. [3] UK Pharmaceutical employment of 73,000 in 2017 [4] compares to 114,000 as of 2015 in Germany, [5] 92,000 as of 2014 in France [6] and 723,000 in the European Union as a whole. [6]